BIOMAT Database Logo BIOMAT Database Logo

Synthetic Cannabinoid-Associated Coagulopathy: Case Report. 2019

Weronika Micula-Gondek, and Vanessa Ruales, and Colleen Zorn, and Andrew Angelino
Johns Hopkins University School of Medicine, Department of Psychiatry and Behavioral Sciences at Howard County, Columbia, MD. Electronic address: wmicula1@jhmi.edu.

UI MeSH Term Description Entries
D010314 Partial Thromboplastin Time The time required for the appearance of FIBRIN strands following the mixing of PLASMA with phospholipid platelet substitute (e.g., crude cephalins, soybean phosphatides). It is a test of the intrinsic pathway (factors VIII, IX, XI, and XII) and the common pathway (fibrinogen, prothrombin, factors V and X) of BLOOD COAGULATION. It is used as a screening test and to monitor HEPARIN therapy. Activated Partial Thromboplastin Time,Cephalin-Kaolin Coagulation Time,Kaolin-Cephalin Coagulation Time,Thromboplastin Time, Partial,Coagulation Time, Cephalin-Kaolin,Cephalin Kaolin Coagulation Time,Coagulation Time, Cephalin Kaolin,Coagulation Time, Kaolin-Cephalin,Kaolin Cephalin Coagulation Time
D010949 Plasma The residual portion of BLOOD that is left after removal of BLOOD CELLS by CENTRIFUGATION without prior BLOOD COAGULATION. Blood Plasma,Fresh Frozen Plasma,Blood Plasmas,Fresh Frozen Plasmas,Frozen Plasma, Fresh,Frozen Plasmas, Fresh,Plasma, Blood,Plasma, Fresh Frozen,Plasmas,Plasmas, Blood,Plasmas, Fresh Frozen
D011517 Prothrombin Time Clotting time of PLASMA recalcified in the presence of excess TISSUE THROMBOPLASTIN. Factors measured are FIBRINOGEN; PROTHROMBIN; FACTOR V; FACTOR VII; and FACTOR X. It is used for monitoring anticoagulant therapy with COUMARINS. Quick Test,Russell's Viper Venom Time,Thrombotest,Russell Viper Venom Time,Russells Viper Venom Time,Prothrombin Times,Test, Quick,Time, Prothrombin,Times, Prothrombin
D001778 Blood Coagulation Disorders Hemorrhagic and thrombotic disorders that occur as a consequence of abnormalities in blood coagulation due to a variety of factors such as COAGULATION PROTEIN DISORDERS; BLOOD PLATELET DISORDERS; BLOOD PROTEIN DISORDERS or nutritional conditions. Coagulation Disorders, Blood,Disorders, Blood Coagulation,Blood Coagulation Disorder,Coagulation Disorder, Blood,Disorder, Blood Coagulation
D002186 Cannabinoids Compounds having the cannabinoid structure. They were originally extracted from Cannabis sativa L. The most pharmacologically active constituents are TETRAHYDROCANNABINOL; CANNABINOL; and CANNABIDIOL. Cannabinoid
D004340 Drug Contamination The presence of organisms, or any foreign material that makes a drug preparation impure. Drug Adulteration,Drug Contamination, Chemical,Drug Contamination, Microbial,Drug Contamination, Physical,Drug Impurity,Adulteration, Drug,Chemical Drug Contamination,Chemical Drug Contaminations,Contamination, Chemical Drug,Contamination, Drug,Contamination, Microbial Drug,Contamination, Physical Drug,Contaminations, Chemical Drug,Contaminations, Microbial Drug,Contaminations, Physical Drug,Drug Adulterations,Drug Contaminations,Drug Contaminations, Chemical,Drug Contaminations, Microbial,Drug Contaminations, Physical,Drug Impurities,Impurity, Drug,Microbial Drug Contamination,Microbial Drug Contaminations,Physical Drug Contamination,Physical Drug Contaminations
D005260 Female Females
D006417 Hematuria Presence of blood in the urine. Hematurias
D006471 Gastrointestinal Hemorrhage Bleeding in any segment of the GASTROINTESTINAL TRACT from ESOPHAGUS to RECTUM. Hematochezia,Hemorrhage, Gastrointestinal,Gastrointestinal Hemorrhages,Hematochezias
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

Weronika Micula-Gondek, and Vanessa Ruales, and Colleen Zorn, and Andrew Angelino
Synthetic Cannabinoid-Associated Coagulopathy.
January 2019, The New England journal of medicine,
Weronika Micula-Gondek, and Vanessa Ruales, and Colleen Zorn, and Andrew Angelino
Synthetic Cannabinoid-Associated Coagulopathy.
January 2019, The New England journal of medicine,
Weronika Micula-Gondek, and Vanessa Ruales, and Colleen Zorn, and Andrew Angelino
Synthetic Cannabinoid-Associated Coagulopathy.
January 2019, The New England journal of medicine,
Weronika Micula-Gondek, and Vanessa Ruales, and Colleen Zorn, and Andrew Angelino
Coagulopathy After Synthetic Cannabinoid Use: A Case Report.
October 2019, Annals of internal medicine,
Weronika Micula-Gondek, and Vanessa Ruales, and Colleen Zorn, and Andrew Angelino
Bad weed: synthetic cannabinoid-associated coagulopathy.
February 2019, Blood,
Weronika Micula-Gondek, and Vanessa Ruales, and Colleen Zorn, and Andrew Angelino
An Outbreak of Synthetic Cannabinoid-Associated Coagulopathy in Illinois.
September 2018, The New England journal of medicine,
Weronika Micula-Gondek, and Vanessa Ruales, and Colleen Zorn, and Andrew Angelino
Brodifacoum contamination of synthetic cannabinoid causing unexplained coagulopathy in multiple trauma: A case report.
June 2024, Trauma case reports,
Weronika Micula-Gondek, and Vanessa Ruales, and Colleen Zorn, and Andrew Angelino
Persistent Coagulopathy After Synthetic Cannabinoid Use.
March 2023, Cureus,
Weronika Micula-Gondek, and Vanessa Ruales, and Colleen Zorn, and Andrew Angelino
Synthetic cannabinoid: an unexpected cause of coagulopathy.
November 2018, Transfusion,
Weronika Micula-Gondek, and Vanessa Ruales, and Colleen Zorn, and Andrew Angelino
[Synthetic Cannabinoid Receptor Agonist-Associated Psychotic Disorder: A Case Report].
January 2016, Turk psikiyatri dergisi = Turkish journal of psychiatry,
Copied contents to your clipboard!